Abstract Details
|
Maria del Pilar Guillermo Prieto Eibl, MD
(Ohio State University The Ohio State University Comprehensive Cancer Center The James - Brain and Spine Tumor Center)
PRESENTER |
Dr. Guillermo Prieto Eibl has nothing to disclose. |
| Pierre Giglio, MD (The Ohio State University) | Dr. Giglio has nothing to disclose. |
| Vinaykumar Puduvalli, MD (The University of Texas MD Anderson Cancer Center) | Dr. Puduvalli has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Insightec . Dr. Puduvalli has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novocure. Dr. Puduvalli has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bayer. An immediate family member of Dr. Puduvalli has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Newave . Dr. Puduvalli has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Servier. Dr. Puduvalli has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Insightec, Novocure, Bayer, Servier, . An immediate family member of Dr. Puduvalli has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Newave . Dr. Puduvalli has stock in Gilead. Dr. Puduvalli has stock in Moderna. The institution of Dr. Puduvalli has received research support from Merck, Servier, Bexion, Karyopharm, Samus therapeutics. |